Vectus Biosystems Ltd (VBS) - Total Liabilities

Latest as of June 2025: AU$1.04 Million AUD ≈ $735.36K USD

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has total liabilities worth AU$1.04 Million AUD (≈ $735.36K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore VBS cash flow conversion to assess how effectively this company generates cash.

Vectus Biosystems Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Vectus Biosystems Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Vectus Biosystems Ltd Competitors by Total Liabilities

The table below lists competitors of Vectus Biosystems Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
RWS Holdings PLC LSE:RWS	UK	GBX277.70 Million
Comperia.pl S.A. WAR:CPL	Poland	zł12.86 Million
J-Star Holding Co., Ltd. Ordinary Shares NASDAQ:YMAT	USA	$11.38 Million
Winshear Gold Corp V:WINS	Canada	CA$191.41K
Xamble Group Ltd AU:XGL	Australia	AU$2.12 Million
Dermata Therapeutics Inc NASDAQ:DRMA	USA	$1.11 Million
Rare Earth Magnesium Technology Group Holdings Limited STU:GPS	Germany	€895.62 Million
Spenda Ltd AU:SPX	Australia	AU$13.22 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Vectus Biosystems Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Vectus Biosystems Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-4.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vectus Biosystems Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual total liabilities of Vectus Biosystems Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.04 Million ≈ $735.36K	+92.72%
2024-06-30	AU$539.26K ≈ $381.56K	-51.26%
2023-06-30	AU$1.11 Million ≈ $782.91K	-86.76%
2022-06-30	AU$8.36 Million ≈ $5.91 Million	-15.39%
2021-06-30	AU$9.88 Million ≈ $6.99 Million	+1.75%
2020-06-30	AU$9.71 Million ≈ $6.87 Million	+147.42%
2019-06-30	AU$3.92 Million ≈ $2.78 Million	+59.99%
2018-06-30	AU$2.45 Million ≈ $1.74 Million	+306.08%
2017-06-30	AU$603.99K ≈ $427.36K	-35.45%
2016-06-30	AU$935.75K ≈ $662.10K	+83.27%
2015-06-30	AU$510.57K ≈ $361.26K	-22.93%
2014-06-30	AU$662.45K ≈ $468.73K	+28.40%
2013-06-30	AU$515.93K ≈ $365.06K	-56.18%
2012-06-30	AU$1.18 Million ≈ $833.07K	--

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.16 Million

AU$5.88 Million AUD

Market Cap Rank

#28685 Global

#1625 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.04 - AU$0.44

All Time High

AU$2.00